On 28 September, Jeremy Veenstra-VanderWeele, professor of psychiatry at Columbia University, spoke about goals for developing new drugs for autism — and the barriers researchers may encounter.
Professor of psychiatry, Columbia University
Jeremy Veenstra-VanderWeele uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism.
The Spectrum Webinar Series aims to facilitate the free exchange of ideas among autism researchers, including discussion of published and unpublished research, hypotheses and results. Members of the press may report information presented during a Spectrum webinar only
if that material has already been published elsewhere or
they have first obtained express written consent from the presenter.
Presentations by leading experts that showcase new findings, useful techniques and emerging topics in autism research. We invite questions before and during the presentations in the Comments section.